September 16, 2020

Tempus and LabCorp Announce Collaboration to Accelerate Clinical Trial Patient Participation

CHICAGO & BURLINGTON, N.C.–(BUSINESS WIRE)–Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, and LabCorp (NYSE: LH), a leading global life sciences company, today announced a collaboration with LabCorp’s drug development business, Covance. LabCorp will participate in Tempus’s TIME Trial® Network and the companies will work together to accelerate patient enrollment for oncology clinical trials through an innova


Leave Comment


Your Name *
Your Email *
Your Website
Comment *